AMIX - צמיחת הכנסות ב-12 חודשים נגררים Autonomix Medical, Inc.

Partnerships with neuromodulation surgical centers strengthen the credit profile of Autonomix Medical, Inc. (AMIX). The trailing 12-month sales performance relative to the prior year demonstrates pricing resilience, while 0.00 determines the latest valuation metric. Financial reserves are supported by the implementation of ESG standards in catheter production and the large-scale deployment of robotic systems featuring AI-driven processing of electrophysiological data.
Autonomix Medical Inc. (AMIX) - פילוחי מדדים ודוחות פיננסיים

To filter risks for Autonomix Medical, Inc. (AMIX), it is essential to distinguish random revenue spikes from the sustainable development of the commercial model. The dynamics of this metric, reflecting the percentage change in total sales over the last twelve months relative to the same period last year, allow for an assessment of business viability through the rolling annual sales growth trend amid limited capital and stringent regulatory pressure on neurosensory technologies.